Aupeg

About this medicine

Originator: ONCASPAR by SIGMA TAU · Manufacturer: Kings Global Biotech Ltd. Indication & Dosage: AUPEG (Pegaspargase), Generic ONCASPAR is a prescription medicine used to treat of acute Lymphoblastic Leukemia (ALL) in both pediatric and adult patients. Pegaspargase is commonly administered as part of a multi-agent chemotherapeutic regimen, which may include drugs such as anthracyclines, vincristine, and corticosteroids. The mechanism of action of Pegaspargase involves the depletion of the amino acid asparagine, which is essential for the survival of tumor cells. By depriving the tumor cells of asparagine, Pegaspargase induces apoptosis, leading to the death of the malignant cells. This medication is typically delivered through intravenous infusion or intramuscular injection, depending on the specific treatment protocol and patient needs. AUPEG is manufactured by by Kings Global Biotech Ltd. in India. Pegaspargase medication is given by injection into a vein by a health care professi Side Effects: The most common side effects of Pegaspargase are: Nausea , vomiting , weakness , diarrhea , or pain/swelling/redness. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.